Archive for March 14th, 2007|Daily archive page

found on the nanotechnology law report blog

In Health, nano on March 14, 2007 at 1:59 am

the report can be found here

the write up from the nanotechnology law report blog
New Report Warns of Nanotechnology Risks in Cosmetics

By Tim Cahill:

On February 20, 2007, the Investor Environmental Health Network (“IEHN”) issued a report entitled “Beneath the Skin: Hidden Liabilities, Market Risk and Drivers of Change in the Cosmetics and Personal Care Products Industry.” IEHN represents 20 investment organizations with $22 billion under management that are seeking to ensure that the companies they invest in are taking appropriate steps to reduce risks associated with the toxic chemicals used in their products. The IEHN’s report warns that nanotechnologies represent one of the significant health risks in the cosmetics industry and that investors in this industry must be aware that sweeping changes are likely to occur in this market. The report describes the Food and Drug Administration’s (“FDA”) current oversight of cosmetics as a “a porous and ill-defined regulatory framework” and cites to the fact that “cosmetics are generally exempt from pre-market review” as a major limitation in the FDA’s ability to regulate cosmetics. As a result, the report recommends that cosmetics manufacturers take independent steps to monitor the safety of their products in order to avoid potential liability and gain a competitive advantage by increasing their brand trust.

The IEHN’s report is certainly not the first to blast the FDA’s ability to regulate the use of nanotechnologies in cosmetics. In an October 2006 report by former FDA Deputy Commissioner for Policy, Michael R. Taylor, entitled “Regulating the Products of Nanotechnology: Does FDA Have the Tools It Needs?,” the FDA’s lack of oversight of cosmetics was identified as an area that must be addressed in order for the FDA to adequately monitor the safety of cosmetics containing nanotechnologies, particularly since cosmetic products with nanomaterials are reaching the marketplace faster than many other products regulated by the FDA. The IEHN’s report recommends greater self-regulation by cosmetics manufacturers, but the FDA could impose stricter regulations in this area in the near future. The FDA is in the process of evaluating its ability to effectively regulate the use of nanomaterials in FDA-regulated products, and it has been reported that the agency will issue its findings in July 2007. How the FDA addresses cosmetics with nanomaterials will be one area to watch closely.

blood tests for mental health conditions under development

In Health on March 14, 2007 at 1:46 am

Based on study results from the University of Iowa, blood tests for panic disorder and other mental health conditions are now being developed at UI and will become commercially available in the near future.
more at source

The Brain on the Stand

In Uncategorized on March 14, 2007 at 1:42 am

an article by By JEFFREY ROSEN Published: March 11, 2007
about neurotech and impact on law
more at source

Buy your portable brain-computer interface here

In Disabled People, Health, nano on March 14, 2007 at 1:37 am

If you can’t wait until next year to get your hands on a Project Epoc EEG cap, never fear: a German company called g.tec (Guger Technologies) is now offering the world’s first commercially available brain computer interface (BCI).
more at source

Singapore is arming teachers with educational nanotechnology kits

In nano on March 14, 2007 at 1:31 am

more at source

Synthetic Biology on Display

In Uncategorized on March 14, 2007 at 1:29 am

more at source

TR10: Neuron Control

In Disabled People on March 14, 2007 at 1:28 am

Karl Deisseroth’s genetically engineered “light switch,” which lets scientists turn selected parts of the brain on and off, may help improve treatments for depression and other disorders.
more at source

Nano memory

In nano on March 14, 2007 at 1:26 am

more at source